CFO of Avadel Pharmaceuticals Plc (30-Year Financial, Insider Trades) Thomas S Mchugh (insider trades) bought 10,000 shares of AVDL on 08/13/2020 at an average price of $7.78 a share. The total cost of this purchase was $77,800.
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company developing and commercializing pharmaceutical products. The company's products include Bloxiverz, Vazculep, Akovaz, Karbinal ER, AcipHex Sprinkle, Cefaclor and Flexichamber. Avadel Pharmaceuticals PLC has a market cap of $496.620 million; its shares were traded at around $8.53 with a P/E ratio of 53.30 and P/S ratio of 7.65. GuruFocus has detected 3 severe warning signs with Avadel Pharmaceuticals PLC. .
CEO Recent Trades:
-
CEO Gregory J Divis bought 13,000 shares of AVDL stock on 08/12/2020 at the average price of $7.78. The price of the stock has increased by 9.64% since.
CFO Recent Trades:
-
CFO Thomas S Mchugh bought 10,000 shares of AVDL stock on 08/13/2020 at the average price of $7.78. The price of the stock has increased by 9.64% since.
Directors and Officers Recent Trades:
-
Director Linda Palczuk bought 2,500 shares of AVDL stock on 08/14/2020 at the average price of $7.94. The price of the stock has increased by 7.43% since.
-
Director Eric J Ende bought 5,000 shares of AVDL stock on 08/13/2020 at the average price of $7.79. The price of the stock has increased by 9.5% since.
-
Director Geoffrey Michael Glass bought 13,000 shares of AVDL stock on 08/13/2020 at the average price of $7.73. The price of the stock has increased by 10.35% since.
-
Director Eric J Ende bought 15,000 shares of AVDL stock on 08/12/2020 at the average price of $7.76. The price of the stock has increased by 9.92% since.
For the complete insider trading history of AVDL, click here
.This article first appeared on GuruFocus.